Trial Profile
Piperacillin/Tazobactam for Prophylaxis in Patients of Neutropenia After Hematopoietic Stem Cell Transplantation - A Pilot Study
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary) ; Piperacillin
- Indications Bacterial infections; Febrile neutropenia
- Focus Therapeutic Use
- 03 Dec 2012 New trial record